Logo (Logo)
Pregabalin Capsule
Product Images NDC 31722-611
21 FDA label images from Camber Pharmaceuticals, Inc. · Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 21 technical images submitted to the FDA as part of the official labeling for Pregabalin (NDC 31722-611). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Camber Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Pregabalinfigure1 (Pregabalinfigure1)
A line graph showing the percent of patients improved on the vertical axis and percent improvement in pain from baseline on the horizontal axis. It compares outcomes for Pregabalin capsules at 25 mg, 100 mg, and 200 mg three times a day, along with a placebo group, illustrating differences in patient pain improvement levels among these treatments.*
Pregabalinfigure10 (Pregabalinfigure10)
A line graph showing the estimated percentage of subjects without LTR over 180 days, comparing Pregabalin and Placebo groups. The graph displays a higher percentage of subjects without LTR in the Pregabalin group throughout the observation period.*
Pregabalinfigure11 (Pregabalinfigure11)
A line graph depicting the percent of subjects improved on the vertical axis against the percent improved from baseline to Week 12 on the horizontal axis. Two lines represent Pregabalin and Placebo, showing differences in improvement percentages over time.*
Pregabalinfigure12 (Pregabalinfigure12)
A line graph comparing the percentage of subjects improved over time from baseline to week 16 in a study, with Pregabalin and Placebo groups represented by two lines. The x-axis shows the percent improved from baseline to week 16, and the y-axis shows the percent of subjects improved.*
Pregabalinfigure2 (Pregabalinfigure2)
A line graph depicting the percentage of patients improved versus percent improvement in pain from baseline. The graph compares Pregabalin 100 mg taken three times a day to placebo, showing distinct curves for each treatment group across the range of pain improvement percentages.*
Pregabalinfigure3 (Pregabalinfigure3)
A line graph showing percent of patients improved on the vertical axis and percent improvement in pain from baseline on the horizontal axis. The figure compares the effects of Pregabalin at doses of 75 mg, 150 mg, and 300 mg taken twice a day against placebo over a range of pain improvement percentages.*
Pregabalinfigure4 (Pregabalinfigure4)
A line graph showing the percent of patients improved versus percent improvement in pain from baseline, comparing Pregabalin 200 mg three times a day, Pregabalin 100 mg three times a day, and placebo groups. The graph presents patient response distribution across varying pain improvement levels.*
Pregabalinfigure5 (Pregabalinfigure5)
A line graph comparing the percent improvement in pain from baseline with the percent of patients improved for Pregabalin 100 mg three times a day, Pregabalin 50 mg three times a day, and placebo groups. The x-axis represents percent improvement in pain, and the y-axis shows the percent of patients improved, illustrating the efficacy difference between the dosages and placebo.*
Pregabalinfigure6 (Pregabalinfigure6)
A bar graph titled 'Study E1' and 'Study E3' showing responder rates (%) on the vertical axis for different treatments, including placebo and various doses of the drug. The horizontal axis lists treatments by dose and frequency. Data bars illustrate responder rates across groups, with statistical significance notes indicated.*
Pregabalinfigure7 (Pregabalinfigure7)
A line chart comparing seizure reduction (%) from baseline to dose (mg/day) for Pregabalin by study and dosing schedule. Four series are shown: Study E1 BID, Study E2 TID, Study E3 BID, and Study E3 TID, illustrating seizure reduction increasing with higher doses up to 600 mg/day with statistical significance noted (p ≤ 0.0001).*
Pregabalinfigure9 (Pregabalinfigure9)
A line graph comparing percent of patients improved versus percent improvement in pain from baseline for Pregabalin at 600 mg, 450 mg, and 300 mg daily doses, along with placebo. The graph includes vertical reference lines at 30, 50, and 60 percent improvement marks, illustrating higher patient improvement rates with Pregabalin doses compared to placebo.*
Pregabalinstructure (Pregabalinstructure)
Chemical structure diagram of Pregabalin, showing its molecular components and arrangement relevant to the active ingredient.*
Pregablin Capsules 100 Container 60 (Pregablin Capsules 100 Container 60)
Packaging label for Pregabalin Capsules 100 mg by Camber Pharmaceuticals, Inc. The label includes storage instructions, a pharmacist advisory to dispense the medication guide, and states it is Rx only. The package contains 60 capsules and includes contact information and manufacturing details.*
Pregablin Capsules 150 Container 60 (Pregablin Capsules 150 Container 60)
Pregabalin 150 mg oral capsules label from Camber Pharmaceuticals, Inc. The label states each capsule contains 150 mg of Pregabalin and includes storage instructions, a pharmacist dispensing note, a barcode, and manufacturer information. The package contains 60 capsules and is marked Rx only.*
Pregablin Capsules 200 Container 60 (Pregablin Capsules 200 Container 60)
Pregabalin 200 mg capsules label from Camber Pharmaceuticals, Inc. The label states each capsule contains 200 mg of Pregabalin and includes storage instructions, pharmacist dispensing guidance, and contact information. The package contains 60 capsules and is marked Rx only. It is manufactured for Camber Pharmaceuticals by Hetero Labs Limited, India.*
Pregablin Capsules 225 Container 60 (Pregablin Capsules 225 Container 60)
Pregabalin Capsules 225 mg oral capsules label from Camber Pharmaceuticals, Inc. The label includes the NDC 31722-616-60 and states a container count of 60 capsules. It provides storage instructions at 20° to 25°C and advises dispensing in tight containers. The label includes a barcode, a pharmacist medication guide notice, and manufacturing information indicating production for Camber Pharmaceuticals by Hetero Labs Limited, Hyderabad, India.*
Pregablin Capsules 25 Container 60 (Pregablin Capsules 25 Container 60)
Pregabalin Capsules 25 mg by Camber Pharmaceuticals, Inc. The label states each capsule contains 25 mg of Pregabalin. It includes storage instructions, prescription and pharmacist dispensing notes, and contact information. The package size is 60 capsules. The label also displays a barcode and manufacturing details from Hetero Labs Limited, India.*
Pregablin Capsules 300 Container 60 (Pregablin Capsules 300 Container 60)
Pregabalin Capsules 300 mg oral capsules label by Camber Pharmaceuticals, Inc. The label states the strength as 300 mg with a count of 60 capsules. It includes storage instructions, a pharmacist note about dispensing the medication guide, a U.S. contact number, and manufacturing information indicating production by Hetero Labs Limited in Hyderabad, India, for Camber Pharmaceuticals in Piscataway, NJ.*
Pregablin Capsules 50 Container 60 (Pregablin Capsules 50 Container 60)
Pregabalin Capsules 50 mg oral capsules packaging label from Camber Pharmaceuticals, Inc. The label includes the product name, strength, quantity of 60 capsules, and storage instructions. It also shows the NDC number 31722-611-60, barcode, manufacturer details, and a warning to dispense the medication guide to each patient.*
Pregablin Capsules 75 Container 60 (Pregablin Capsules 75 Container 60)
Pregabalin Capsules 75 mg label from Camber Pharmaceuticals, Inc. The label indicates 60 capsules per container, with storage instructions at 20° to 25°C (68° to 77°F). It includes pharmacy dispensing information, contact details, and manufacturing details by Hetero Labs Limited, India. A barcode is present, and the label highlights a 43 x 30 mm unvarnished area.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
